Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study
Blood Press
.
2024 Dec;33(1):2394448.
doi: 10.1080/08037051.2024.2394448.
Epub 2024 Sep 6.
Authors
Reinhold Kreutz
1
,
Mattias Brunström
2
,
Sverre E Kjeldsen
3
,
Krzysztof Narkiewicz
4
,
Brent Egan
5
,
Michel Burnier
6
Affiliations
1
Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
2
Department of Public Health and Clinical Medicine, Umeå University, Sweden.
3
Departments of Cardiology and Nephrology, University of Oslo, Ullevaal Hospital, Oslo, Norway.
4
Department of Hypertension and Diabetology, Medical University of Gdansk, Poland.
5
University of South Carolina, Greenville, USA.
6
Faculty of Biology and Medicine, University of Lausanne, Switzerland.
PMID:
39241222
DOI:
10.1080/08037051.2024.2394448
No abstract available
Publication types
Editorial
MeSH terms
Antihypertensive Agents* / therapeutic use
Blood Pressure* / drug effects
Humans
Hypertension* / drug therapy
Hypertension* / physiopathology
Systole
Substances
Antihypertensive Agents